+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contract Research Outsourcing - Global Strategic Business Report

  • PDF Icon

    Report

  • 453 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 347964
The global market for Contract Research Outsourcing is estimated at US$53.2 Billion in 2023 and is projected to reach US$90.4 Billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the contract research outsourcing market is driven by several factors that reflect the changing landscape of the pharmaceutical and biotech industries. One of the primary drivers is the increasing R&D expenditure by pharmaceutical companies seeking to develop new therapies and maintain a competitive edge. The rising complexity of clinical trials, particularly in areas such as oncology and personalized medicine, necessitates specialized expertise and capabilities that CROs can provide. Additionally, the growing trend of virtual and decentralized clinical trials, accelerated by the COVID-19 pandemic, has further fueled the demand for CRO services. Regulatory pressures and the need for stringent data management and reporting also drive companies to outsource to ensure compliance and mitigate risks. Moreover, the expansion of biopharmaceuticals and the focus on rare diseases and orphan drugs have created new opportunities for CROs to support innovative research initiatives. These factors, combined with advancements in technology and an increasingly collaborative approach to drug development, ensure robust growth and continued evolution in the contract research outsourcing market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Clinical Research Services segment, which is expected to reach US$61.2 Billion by 2030 with a CAGR of a 8.2%. The Discovery Research Services segment is also set to grow at 6.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $21.5 Billion in 2023, and China, forecasted to grow at an impressive 10.2% CAGR to reach $5.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Contract Research Outsourcing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Contract Research Outsourcing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Contract Research Outsourcing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Charles River Laboratories International, Inc., Galapagos NV, Albany Molecular Research, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 152 Featured):

  • Charles River Laboratories International, Inc.
  • Galapagos NV
  • Albany Molecular Research, Inc.
  • Axxam SpA
  • Cyprotex Limited
  • BioClinica
  • HD Biosciences Co., Ltd.
  • Clinipace Inc.
  • CMIC Holdings Co., Ltd.
  • EAG Laboratories
  • Envigo, Inc.
  • Genoway S.A.
  • EPS International Co., Ltd.
  • GenScript Biotech Corporation
  • Absorption Systems LLC

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Contract Research Outsourcing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Contract Research Outsourcing: An Introduction
  • Key Service Markets
  • Market Dynamics
  • Key Therapeutic Areas of Clinical Trial Research
  • Global Clinical Trial Services Market by Therapeutic Area: 2023
  • Top 6 Therapeutic Categories by Number of R&D Products in 2023
  • Cost Savings Hold Relevance
  • Product Innovations & Enhanced Speed
  • Access to Expertise & Sophisticated Technology
  • Outlook
  • Regional Market Analysis
  • Future Model of CRO
  • COMPETITIVE SCENARIO
  • CRO: A Highly Fragmented Market
  • Leading Players in the Global Contract Research Outsourcing Market (2023): Percentage Breakdown of Revenues by Player
  • Partnership Models Pay Returns
  • Strategies and Tactical Programs
  • Large CROs Seek the Inorganic Growth Route
  • Key Opportunities for CROs
  • Technological Superiority: An Advantage
  • Consolidation to Gain Pace
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Uptrend in Advanced Medicine Concepts Favors Growth
  • Drug Developers Bet on CROs to Sail through Challenging Aspects
  • Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
  • Gene Therapy Offers Exciting Opportunities for CROs
  • Gene Therapy Set to Witness Rapid Growth
  • Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
  • Increasing Significance of Biologic Drugs Supports Market Demand
  • Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
  • Opportunities Rife in Early Stage Drug Development
  • Notable Trends in Pharma/Biopharma R&D Impacting CROs
  • Advances in Digital/Technology and its Impact on Clinical Development
  • Significant Strides Taken in the Sphere of Current Clinical Research
  • Data Quality Oversight (DQO) Undergoes Change
  • Pharmacovigilance Set to Grow
  • Artificial Intelligence and Machine Learning Gain Interest
  • Orphan Drugs to the Fore
  • CROs Adapt New Technologies to See More Business in Future
  • Streamlining Development of Novel Trial Designs
  • Industry Witnesses Increased Spend on R&D Outsourcing
  • Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
  • Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2023
  • Focus on Enhancing Site Selection and Patient Enrollment
  • CROs Enter into Alliances to Improve Efficiencies
  • Adoption of Digital Technologies Gains Pace
  • Toxicology Services Gain Notable Attention
  • Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
  • Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
  • Global Biopharma % R&D Outsourcing (2014-2023)
  • New FDA Drug Approvals : Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals for 2023
  • eClinical Solutions Gain Traction
  • Other Noteworthy Market Trends
  • Challenges Faced by Contract Research Organizations
  • Surging Global Population Offers Increased Growth Opportunities
  • World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
  • Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Contract Research Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Market Overview
  • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
  • Trial Services Witness Strong Demand
  • High Demand for Data Management Services
  • Risk-based Monitoring Catches Pace
  • Market Analytics
CANADA
JAPAN
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Market Overview
EUROPE
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Market Overview
  • CRO Industry in Europe Gears Up for Broad-based Amendments
  • Providers Expand Services in Downstream Drug Development
  • Market Analytics
FRANCE
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Market Overview
  • Asia-Pacific to Push Up Volume Share in CRO Market
  • R&D Outsourcing in Life Sciences on Rise
  • Market Analytics
INDIA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Indian CROs Seek Opportunities
REST OF ASIA-PACIFIC
  • Market Overview
  • Australia: Popular Destination for Early Phase Clinical Trials
  • Market Analytics
LATIN AMERICA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Charles River Laboratories International, Inc.
  • Galapagos NV
  • Albany Molecular Research, Inc.
  • Axxam SpA
  • Cyprotex Limited
  • BioClinica
  • HD Biosciences Co., Ltd.
  • Clinipace Inc.
  • CMIC Holdings Co., Ltd.
  • EAG Laboratories
  • Envigo, Inc.
  • Genoway S.A.
  • EPS International Co., Ltd.
  • GenScript Biotech Corporation
  • Absorption Systems LLC

Table Information